- Size
- 10mg
- Purity
- 99.79%
- Formula
- C43H66N12O12S2
Oxytocin is a nine-amino-acid neuropeptide with an internal disulfide bridge, synthesised in the paraventricular and supraoptic nuclei of the hypothalamus. Peripherally it acts on a single identified G-protein-coupled oxytocin receptor in uterine and mammary tissue; centrally, oxytocinergic projections reach the amygdala, hippocampus, striatum, and brainstem, which is the anatomical basis for its use in social-neuroscience research.
The experimental literature is dominated by intranasal administration in healthy volunteers. Landmark studies report changes in trust behaviour in economic games and in performance on emotion-recognition tasks, alongside functional imaging work describing altered amygdala reactivity to emotional faces. The interpretation of these findings is actively contested: a substantial methodological literature questions how much intranasally applied peptide reaches the central nervous system, how reliably the behavioural effects replicate, and whether peripheral or expectancy pathways contribute.
Reviews of the field converge on a set of practical caveats — small sample sizes, publication bias, sex and context dependence of effects, and inconsistent dosing and device protocols. Contemporary guidance for study design emphasises pre-registration and larger samples rather than treating the earlier results as settled.
Categorised as Cognitive — Neuropeptides for neuroscience research.For research purposes only. Not for human consumption, diagnosis, treatment, or prevention of any condition.